MedTrace Logo

Evaluation of a Beverage Media Campaign and Added-sugar Warning Labels

NCT05563181 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2275

Last updated 2025-08-01

No results posted yet for this study

Summary

The primary objective of this study is to examine differences in intentions (measured by hypothetical beverage selection) between the following conditions: (1) Control condition: Viewing beverages with a barcode, (2) viewing beverages that have an icon-plus-text warning label, "WARNING: High in added sugar", (3) viewing a campaign message about warning labels in one's preferred language + viewing beverages with a barcode, and (4) viewing a campaign message about warning labels in one's preferred language + viewing beverages with the warning label above. An additional objective is to compare other message reactions and perceptions and perceptions of SSBs (sugar-sweetened beverages) between the conditions. This study will use an online randomized controlled trial among Latino/a/x adults to assign participants to one of the above conditions.

Conditions

  • Attitude
  • Intention

Interventions

BEHAVIORAL

Control bar code label

Viewing beverages that contain control labels (i.e., bar codes) on sugar-sweetened beverages

BEHAVIORAL

Warning label

Viewing beverages that contain an added-sugar warning label (icon-plus-text yellow label that says, "WARNING: High in added sugar," on sugar-sweetened beverages

BEHAVIORAL

Informational campaign poster about added-sugar warning labels

Viewing an informational campaign about added-sugar warning labels. The poster will be shown in Spanish (instead of English) if the participant reports speaking and reading in Spanish better than English.

Sponsors & Collaborators

  • University of California, Davis

    lead OTHER

Principal Investigators

  • Jennifer Falbe · UC Davis

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-07
Primary Completion
2022-12-05
Completion
2023-03-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05563181 on ClinicalTrials.gov